Clinton Foundation Pens Agreement with Guava for Discounted CD4 Testing Tech

Guava Technologies said this week that the Clinton Foundation HIV/AIDS Initiative (CHAI) has signed an agreement with Guava designed to reduce the cost of CD4 testing for HIV patient monitoring by up to 50 percent.

Under the terms of the agreement, Guava will supply its Easy CD4 System at a discounted price to the members of CHAI's Procurement Consortium, a coalition of 56 developing countries around the world including 27 African nations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.